Viewing Study NCT00909051


Ignite Creation Date: 2025-12-24 @ 11:54 PM
Ignite Modification Date: 2025-12-25 @ 9:49 PM
Study NCT ID: NCT00909051
Status: COMPLETED
Last Update Posted: 2023-06-06
First Post: 2009-05-26
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: GlucoVIP - Diabetes Treatment by Glucobay® With a Special Therapeutic View to Chosen Patient Groups
Sponsor: Bayer
Organization:

Study Overview

Official Title: Diabetes Treatment by Glucobay® With a Special Therapeutic View to Chosen Patient Groups
Status: COMPLETED
Status Verified Date: 2023-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Evaluation of safety and effectiveness of Glucobay® under daily-life treatment conditions in a large sample of patients.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
GB0701 OTHER Company internal View